CAS 1093070-16-6

Fórmula: C20H20N2O

InChI: InChI=1S/C20H20N2O/c1-13-10-11-16(21)12-19(13)20(23)22-14(2)17-9-5-7-15-6-3-4-8-18(15)17/h3-12,14H,21H2,1-2H3,(H,22,23)/t14-/m1/s1

Chave InChI: UVERBUNNCOKGNZ-CQSZACIVSA-N

SMILES: CC1=C(C=C(C=C1)N)C(=O)N[C@H](C)C2=CC=CC3=CC=CC=C32

GRL0617

CAS: 1093070-16-6

GRL0617 is a selective and competitive SARS-CoVPLpro and deubiquitinase noncovalent inhibitor(IC50 : 0.6 μM, Ki : 0.49 μM).

Fórmula: C₂₀H₂₀N₂O

Pureza: 99.31%

Cor e Forma: Solid

Peso molecular: 304.3856

Ref: TM-T11464

GRL0617

CAS: 1093070-16-6

GRL0617

Fórmula: C₂₀H₂₀N₂O

Pureza: ≥98%

Peso molecular: 304.39

Ref: 54-BUP12825

GRL0617

CAS: 1093070-16-6

Fórmula: C₂₀H₂₀N₂O

Pureza: 99%

Cor e Forma: Solid

Peso molecular: 304.3856

Ref: IN-DA01KKBV

GRL 0617

CAS: 1093070-16-6

A novel non-covalent inhibitor of the PLpro protease from SARS-CoV-2 and SARS-CoV viruses. GRL 0617 inhibits the proteolytic processing of the viral polypeptide. As PLpro also acts as a protease in pathways involved in innate immunity, there are indications that it can promote immunity against the virus.

Fórmula: C₂₀H₂₀N₂O

Pureza: Min. 98 Area-%

Cor e Forma: Powder

Peso molecular: 304.39 g/mol

Ref: 3D-BG178727

GRL0617

CAS: 1093070-16-6

(R)-5-amino-2-methyl-N-(1-(naphthalen-1-yl)ethyl)benzamide

Fórmula: C₂₀H₂₀N₂O

Pureza: 99%

Peso molecular: 304.39

Ref: IN-DG01200315